Zurcher Kantonalbank (Zurich Cantonalbank) Allakos Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Allakos Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 8,911 shares of ALLK stock, worth $10,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,911

Previous 8,911 -0.0%

Holding current value

$10,336

Previous $5,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$0.54 - $0.92 $1,337 - $2,278	-2,477 Reduced 21.75%	8,911 $5,000
Q2 2024 Jul 29, 2024	SELL	$1.0 - $1.45 $2,377 - $3,446	-2,377 Reduced 17.27%	11,388 $11,000
Q1 2024 Apr 25, 2024	SELL	$1.02 - $3.23 $449 - $1,424	-441 Reduced 3.1%	13,765 $17,000
Q4 2023 Jan 30, 2024	SELL	$1.72 - $3.18 $493 - $912	-287 Reduced 1.98%	14,206 $38,000
Q3 2023 Oct 25, 2023	SELL	$2.13 - $5.55 $1,018 - $2,652	-478 Reduced 3.19%	14,493 $32,000
Q2 2023 Aug 07, 2023	SELL	$3.6 - $5.25 $2,008 - $2,929	-558 Reduced 3.59%	14,971 $65,000
Q1 2023 May 08, 2023	BUY	$4.3 - $8.27 $11,807 - $22,709	2,746 Added 21.48%	15,529 $69,000
Q4 2022 Feb 01, 2023	BUY	$5.66 - $8.42 $60,601 - $90,152	10,707 Added 515.75%	12,783 $107,000
Q3 2022 Nov 09, 2022	SELL	$3.02 - $6.12 $72 - $146	-24 Reduced 1.14%	2,076 $13,000
Q2 2022 Aug 09, 2022	SELL	$2.6 - $6.14 $12,191 - $28,790	-4,689 Reduced 69.07%	2,100 $7,000
Q1 2022 Apr 21, 2022	SELL	$5.08 - $9.81 $2,367 - $4,571	-466 Reduced 6.42%	6,789 $39,000
Q4 2021 Feb 01, 2022	BUY	$8.55 - $111.89 $11,893 - $155,638	1,391 Added 23.72%	7,255 $71,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $1,147 - $1,656	-15 Reduced 0.26%	5,864 $621,000
Q2 2021 Jul 30, 2021	BUY	$85.37 - $114.1 $11,524 - $15,403	135 Added 2.35%	5,879 $502,000
Q1 2021 May 03, 2021	BUY	$109.73 - $153.66 $337,639 - $472,811	3,077 Added 115.37%	5,744 $659,000
Q3 2020 Nov 06, 2020	BUY	$66.43 - $90.99 $43,312 - $59,325	652 Added 32.36%	2,667 $217,000
Q2 2020 Jul 28, 2020	BUY	$44.04 - $80.69 $25,278 - $46,316	574 Added 39.83%	2,015 $145,000
Q3 2019 Oct 18, 2019	BUY	$31.0 - $89.73 $44,671 - $129,300	1,441 New	1,441 $113,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $98.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Allakos Inc. Transaction History